Reply to a Letter to the Editors From Dr de Souza and colleagues: “Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for Clarity”
- 1 January 2024
- journal article
- letter
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 44 (1) , 76-78
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysisThe Lancet, 2013
- Substance-Induced Psychoses Converting Into SchizophreniaThe Journal of Clinical Psychiatry, 2013
- Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trialBMC Psychiatry, 2011
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialThe Lancet, 2008
- How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trialsMolecular Psychiatry, 2008
- Aripiprazole in the Treatment of Depressive and Anxiety DisordersCNS Drugs, 2008
- Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovationsNature Reviews Drug Discovery, 2006
- Schizophrenia and suicide: Systematic review of risk factorsThe British Journal of Psychiatry, 2005
- Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studiesEuropean Psychiatry, 2005
- Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptomsSchizophrenia Research, 1999